Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 104

1.

Copy number variants in people with autism spectrum disorders and co-morbid psychosis.

Larson FV, Arrand JR, Tantam D, Jones PB, Holland AJ.

Eur J Med Genet. 2018 Apr;61(4):230-234. doi: 10.1016/j.ejmg.2017.12.005. Epub 2017 Dec 7.

PMID:
29225144
2.

Genome diversity of Epstein-Barr virus from multiple tumor types and normal infection.

Palser AL, Grayson NE, White RE, Corton C, Correia S, Ba Abdullah MM, Watson SJ, Cotten M, Arrand JR, Murray PG, Allday MJ, Rickinson AB, Young LS, Farrell PJ, Kellam P.

J Virol. 2015 May;89(10):5222-37. doi: 10.1128/JVI.03614-14. Epub 2015 Mar 18.

3.

Epstein-Barr virus induction of the Hedgehog signalling pathway imposes a stem cell phenotype on human epithelial cells.

Port RJ, Pinheiro-Maia S, Hu C, Arrand JR, Wei W, Young LS, Dawson CW.

J Pathol. 2013 Nov;231(3):367-77. doi: 10.1002/path.4245.

PMID:
23934731
4.

A global view of the oncogenic landscape in nasopharyngeal carcinoma: an integrated analysis at the genetic and expression levels.

Hu C, Wei W, Chen X, Woodman CB, Yao Y, Nicholls JM, Joab I, Sihota SK, Shao JY, Derkaoui KD, Amari A, Maloney SL, Bell AI, Murray PG, Dawson CW, Young LS, Arrand JR.

PLoS One. 2012;7(7):e41055. doi: 10.1371/journal.pone.0041055. Epub 2012 Jul 17.

5.

Detection of single nucleotide polymorphisms within a sequence of a gene associated with prostate cancer using a fluorophore-tagged DNA probe.

Zhao ZY, San M, Duprey JL, Arrand JR, Vyle JS, Tucker JH.

Bioorg Med Chem Lett. 2012 Jan 1;22(1):129-32. doi: 10.1016/j.bmcl.2011.11.053. Epub 2011 Nov 20.

PMID:
22169264
6.

High Myc activity is an independent negative prognostic factor for diffuse large B cell lymphomas.

Schrader A, Bentink S, Spang R, Lenze D, Hummel M, Kuo M, Arrand JR, Murray PG, Trümper L, Kube D, Vockerodt M.

Int J Cancer. 2012 Aug 15;131(4):E348-61. doi: 10.1002/ijc.26423. Epub 2011 Oct 23.

7.

EBV gene expression and regulation.

Young LS, Arrand JR, Murray PG.

In: Arvin A, Campadelli-Fiume G, Mocarski E, Moore PS, Roizman B, Whitley R, Yamanishi K, editors. Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis. Cambridge: Cambridge University Press; 2007. Chapter 27.

8.

Epstein-Barr virus-encoded EBNA1 enhances RNA polymerase III-dependent EBER expression through induction of EBER-associated cellular transcription factors.

Owen TJ, O'Neil JD, Dawson CW, Hu C, Chen X, Yao Y, Wood VH, Mitchell LE, White RJ, Young LS, Arrand JR.

Mol Cancer. 2010 Sep 15;9:241. doi: 10.1186/1476-4598-9-241.

9.

Epstein-Barr virus-encoded EBNA1 inhibits the canonical NF-kappaB pathway in carcinoma cells by inhibiting IKK phosphorylation.

Valentine R, Dawson CW, Hu C, Shah KM, Owen TJ, Date KL, Maia SP, Shao J, Arrand JR, Young LS, O'Neil JD.

Mol Cancer. 2010 Jan 5;9:1. doi: 10.1186/1476-4598-9-1.

10.

Epstein-Barr virus-encoded EBNA1 modulates the AP-1 transcription factor pathway in nasopharyngeal carcinoma cells and enhances angiogenesis in vitro.

O'Neil JD, Owen TJ, Wood VH, Date KL, Valentine R, Chukwuma MB, Arrand JR, Dawson CW, Young LS.

J Gen Virol. 2008 Nov;89(Pt 11):2833-42. doi: 10.1099/vir.0.2008/003392-0.

PMID:
18931081
11.

Epstein-Barr virus-encoded LMP1 induces a hyperproliferative and inflammatory gene expression programme in cultured keratinocytes.

Morris MA, Dawson CW, Wei W, O'Neil JD, Stewart SE, Jia J, Bell AI, Young LS, Arrand JR.

J Gen Virol. 2008 Nov;89(Pt 11):2806-20. doi: 10.1099/vir.0.2008/003970-0.

PMID:
18931079
12.

The Epstein-Barr virus oncoprotein, latent membrane protein-1, reprograms germinal centre B cells towards a Hodgkin's Reed-Sternberg-like phenotype.

Vockerodt M, Morgan SL, Kuo M, Wei W, Chukwuma MB, Arrand JR, Kube D, Gordon J, Young LS, Woodman CB, Murray PG.

J Pathol. 2008 Sep;216(1):83-92. doi: 10.1002/path.2384.

PMID:
18566961
13.

CD154 tone sets the signaling pathways and transcriptome generated in model CD40-pluricompetent L3055 Burkitt's lymphoma cells.

Stewart R, Wei W, Challa A, Armitage RJ, Arrand JR, Rowe M, Young LS, Eliopoulos A, Gordon J.

J Immunol. 2007 Sep 1;179(5):2705-12.

14.

Epstein-Barr virus induces cellular transcription factors to allow active expression of EBER genes by RNA polymerase III.

Felton-Edkins ZA, Kondrashov A, Karali D, Fairley JA, Dawson CW, Arrand JR, Young LS, White RJ.

J Biol Chem. 2006 Nov 10;281(45):33871-80. Epub 2006 Sep 6.

15.
16.
18.

Characterization of an Epstein-Barr virus-related gammaherpesvirus from common marmoset (Callithrix jacchus).

Jenson HB, Ench Y, Zhang Y, Gao SJ, Arrand JR, Mackett M.

J Gen Virol. 2002 Jul;83(Pt 7):1621-33.

PMID:
12075080
19.

High level expression and purification of the Epstein-Barr virus encoded cytokine viral interleukin 10: efficient removal of endotoxin.

Salek-Ardakani S, Stuart AD, Arrand JE, Lyons S, Arrand JR, Mackett M.

Cytokine. 2002 Jan 7;17(1):1-13.

PMID:
11886166
20.

Comparative analysis of the expression of the Epstein-Barr virus (EBV) anti-apoptotic gene BHRF1 in nasopharyngeal carcinoma and EBV-related lymphoid diseases.

Nicholls J, Kremmer E, Meseda CA, Mackett M, Hahn P, Gulley ML, Brink A, Swinnen LJ, Greenspan J, De Souza Y, Grässer F, Sham J, Ng MH, Arrand JR.

J Med Virol. 2001 Sep;65(1):105-13.

PMID:
11505451
21.

Antibodies to Epstein-Barr virus thymidine kinase: a characteristic marker for the serological detection of nasopharyngeal carcinoma.

Connolly Y, Littler E, Sun N, Chen X, Huang PC, Stacey SN, Arrand JR.

Int J Cancer. 2001 Mar 1;91(5):692-7.

22.

Heterogeneity of HLA and EBER expression in Epstein-Barr virus-associated nasopharyngeal carcinoma.

Yao Y, Minter HA, Chen X, Reynolds GM, Bromley M, Arrand JR.

Int J Cancer. 2000 Dec 15;88(6):949-55.

23.

Heparin and heparan sulfate bind interleukin-10 and modulate its activity.

Salek-Ardakani S, Arrand JR, Shaw D, Mackett M.

Blood. 2000 Sep 1;96(5):1879-88.

24.

Leaky scanning is the predominant mechanism for translation of human papillomavirus type 16 E7 oncoprotein from E6/E7 bicistronic mRNA.

Stacey SN, Jordan D, Williamson AJ, Brown M, Coote JH, Arrand JR.

J Virol. 2000 Aug;74(16):7284-97.

25.

Herpesvirus papio encodes a functional homologue of the Epstein-Barr virus apoptosis suppressor, BHRF1.

Meseda CA, Arrand JR, Mackett M.

J Gen Virol. 2000 Jul;81(Pt 7):1801-5.

PMID:
10859386
26.

Epidemiology of herpesvirus papio infection in a large captive baboon colony: similarities to Epstein-Barr virus infection in humans.

Jenson HB, Ench Y, Gao SJ, Rice K, Carey D, Kennedy RC, Arrand JR, Mackett M.

J Infect Dis. 2000 Apr;181(4):1462-6. Epub 2000 Apr 13.

PMID:
10762578
27.

Antigen gene transfer to cultured human dendritic cells using recombinant avipoxvirus vectors.

Brown M, Davies DH, Skinner MA, Bowen G, Hollingsworth SJ, Mufti GJ, Arrand JR, Stacey SN.

Cancer Gene Ther. 1999 May-Jun;6(3):238-45.

28.

Recombinant adeno-associated virus-mediated expression of O6-alkylguanine-DNA-alkyltransferase protects human epithelial and hematopoietic cells against chloroethylating agent toxicity.

Longhurst SJ, Rafferty JA, Arrand JR, Cortez N, Giraud C, Berns KI, Fairbairn LJ.

Hum Gene Ther. 1999 Jan 20;10(2):301-10.

PMID:
10022554
29.

Immunization of common marmosets with Epstein-Barr virus (EBV) envelope glycoprotein gp340: effect on viral shedding following EBV challenge.

Cox C, Naylor BA, Mackett M, Arrand JR, Griffin BE, Wedderburn N.

J Med Virol. 1998 Aug;55(4):255-61.

PMID:
9661832
30.

The processing, transport and heterologous expression of Epstein-Barr virus gp110.

Papworth MA, Van Dijk AA, Benyon GR, Allen TD, Arrand JR, Mackett M.

J Gen Virol. 1997 Sep;78 ( Pt 9):2179-89.

PMID:
9292005
31.

Genetic content and preliminary transcriptional analysis of a representative region of murine gammaherpesvirus 68.

Mackett M, Stewart JP, de V Pepper S, Chee M, Efstathiou S, Nash AA, Arrand JR.

J Gen Virol. 1997 Jun;78 ( Pt 6):1425-33.

PMID:
9191940
32.

Towards gene therapy of Hurler syndrome.

Fairbairn LJ, Lashford LS, Spooncer E, McDermott RH, Lebens G, Arrand JE, Arrand JR, Bellantuono I, Holt R, Hatton CE, Cooper A, Besley GT, Wraith JE, Anson DS, Hopwood JJ, Dexter TM.

Cas Lek Cesk. 1997 Jan 8;136(1):27-31.

PMID:
9127508
33.

Differences in serological IgA responses to recombinant baculovirus-derived human papillomavirus E2 protein in the natural history of cervical neoplasia.

Rocha-Zavaleta L, Jordan D, Pepper S, Corbitt G, Clarke F, Maitland NJ, Sanders CM, Arrand JR, Stern PL, Stacey SN.

Br J Cancer. 1997;75(8):1144-50.

34.

Epstein-Barr virus associated graft failure following heart/lung transplantation.

Egan JJ, Stewart JP, Hasleton PS, Yonan N, Bishop P, Arrand JR, Rahman AN, Carroll KB, Woodcock AA.

Thorax. 1996 Nov;51(11):1160-2; discussion 1164-5.

35.

Immunisation of common marmosets with vaccinia virus expressing Epstein-Barr virus (EBV) gp340 and challenge with EBV.

Mackett M, Cox C, Pepper SD, Lees JF, Naylor BA, Wedderburn N, Arrand JR.

J Med Virol. 1996 Nov;50(3):263-71.

PMID:
8923292
36.

Identification and characterization of murine gammaherpesvirus 68 gp150: a virion membrane glycoprotein.

Stewart JP, Janjua NJ, Pepper SD, Bennion G, Mackett M, Allen T, Nash AA, Arrand JR.

J Virol. 1996 Jun;70(6):3528-35.

38.

Long-term in vitro correction of alpha-L-iduronidase deficiency (Hurler syndrome) in human bone marrow.

Fairbairn LJ, Lashford LS, Spooncer E, McDermott RH, Lebens G, Arrand JE, Arrand JR, Bellantuono I, Holt R, Hatton CE, Cooper A, Besley GT, Wraith JE, Anson DS, Hopwood JJ, Dexter TM.

Proc Natl Acad Sci U S A. 1996 Mar 5;93(5):2025-30.

39.

Epstein-Barr virus replication within pulmonary epithelial cells in cryptogenic fibrosing alveolitis.

Egan JJ, Stewart JP, Hasleton PS, Arrand JR, Carroll KB, Woodcock AA.

Thorax. 1995 Dec;50(12):1234-9.

40.

The Epstein-Barr virus encoded cytokine viral interleukin-10 enhances transformation of human B lymphocytes.

Stuart AD, Stewart JP, Arrand JR, Mackett M.

Oncogene. 1995 Nov 2;11(9):1711-9.

PMID:
7478598
41.
42.

Antigenic and sequence variation in the C-terminal unique domain of the Epstein-Barr virus nuclear antigen EBNA-1.

Wrightham MN, Stewart JP, Janjua NJ, Pepper SD, Sample C, Rooney CM, Arrand JR.

Virology. 1995 Apr 20;208(2):521-30.

43.

Identification of a naturally processed HLA A0201-restricted viral peptide from cells expressing human papillomavirus type 16 E6 oncoprotein.

Bartholomew JS, Stacey SN, Coles B, Burt DJ, Arrand JR, Stern PL.

Eur J Immunol. 1994 Dec;24(12):3175-9.

PMID:
7805746
44.

Characterization of murine gammaherpesvirus 68 glycoprotein B (gB) homolog: similarity to Epstein-Barr virus gB (gp110).

Stewart JP, Janjua NJ, Sunil-Chandra NP, Nash AA, Arrand JR.

J Virol. 1994 Oct;68(10):6496-504.

45.
46.

[Investigation of EB virus DNA BamHI W fragment, EBNA-2 types and EBNA expression in benign and malignant nasopharyngeal biopsies].

Chen XY, Ning S, Arrand JR.

Zhonghua Bing Li Xue Za Zhi. 1994 Aug;23(4):200-3. Chinese.

PMID:
7805145
47.

Paterson symposium 1993--gene therapy.

Fairbairn LJ, Cross MA, Arrand JR.

Br J Cancer. 1994 May;69(5):972-5. No abstract available.

48.

Differential expression of viral and human interleukin-10 (IL-10) by primary B cell tumors and B cell lines.

Stewart JP, Behm FG, Arrand JR, Rooney CM.

Virology. 1994 May 1;200(2):724-32.

PMID:
8178456
49.

Scanning the structure and antigenicity of HPV-16 E6 and E7 oncoproteins using antipeptide antibodies.

Stacey SN, Eklund C, Jordan D, Smith NK, Stern PL, Dillner J, Arrand JR.

Oncogene. 1994 Feb;9(2):635-45. Erratum in: Oncogene 1994 May;9(5):1515.

PMID:
7507231
50.

Delayed-type hypersensitivity response to human papillomavirus type 16 E6 protein in a mouse model.

Chambers MA, Stacey SN, Arrand JR, Stanley MA.

J Gen Virol. 1994 Jan;75 ( Pt 1):165-9.

PMID:
7906707

Supplemental Content

Loading ...
Support Center